drugset / Trial / NCT06273930

Reduction of Dentine Hypersensitivity After Use of Different Dentifrices

NCT06273930

Phase 1 Unknown 87 enrolled Armed Forces Institute of Dentistry, Pakistan
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To assess the impact of the use of 5% Calcium Sodium Phosphosilicate or 8% Arginine dentifrices on dentinal hypersensitivity following non-surgical periodontal therapy in patients with periodontitis.

Timeline

Start
2024-02-01
Primary completion
2024-10-15
Completion
2024-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator L-arginine Small molecule 8 %
Comparator PHOSPHINE SILANE Other / unclassified 5 %

Indications